科研项目详细信息
Development of a preclinical drug candidate for treatment of visceral leishmaniasis through optimisation of scaffolds identified from a phenotypic HTS screen of L. donovani axenic amastigote proliferation
Dr Richard Glynne
Genomics Institute of the Novartis Research Foundation
Subject:医学(综合)
2014至2014
Source: 英国惠康基金会
Link: https://wellcome.org/grant-funding/funded-people-and-projects